JP2012527442A5 - - Google Patents

Download PDF

Info

Publication number
JP2012527442A5
JP2012527442A5 JP2012511355A JP2012511355A JP2012527442A5 JP 2012527442 A5 JP2012527442 A5 JP 2012527442A5 JP 2012511355 A JP2012511355 A JP 2012511355A JP 2012511355 A JP2012511355 A JP 2012511355A JP 2012527442 A5 JP2012527442 A5 JP 2012527442A5
Authority
JP
Japan
Prior art keywords
salt
diffraction pattern
pharmaceutical composition
powder diffraction
ray powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012511355A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012527442A (ja
JP5717727B2 (ja
Filing date
Publication date
Priority claimed from GBGB0908772.7A external-priority patent/GB0908772D0/en
Application filed filed Critical
Publication of JP2012527442A publication Critical patent/JP2012527442A/ja
Publication of JP2012527442A5 publication Critical patent/JP2012527442A5/ja
Application granted granted Critical
Publication of JP5717727B2 publication Critical patent/JP5717727B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012511355A 2009-05-21 2010-05-20 ２−（４−（（２−アミノ−４−メチル−６−（ペンチルアミノ）ピリミジン−５−イル）メチル）フェニル）酢酸４−（ジメチルアミノ）ブチルの二サッカリン塩、二フマル酸塩、二ｌ−ヒドロキシ−２−ナフトエ酸塩および一安息香酸塩 Expired - Fee Related JP5717727B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0908772.7 2009-05-21
GBGB0908772.7A GB0908772D0 (en) 2009-05-21 2009-05-21 New salts 756
PCT/GB2010/050822 WO2010133882A1 (en) 2009-05-21 2010-05-20 Disaccharin, difumaric acid, di-l-hydroxy-2-naphthoic acid and mono-benzoic acid salts of 4- (dimethylamin0)butyl 2- (4- ( (2-amino-4-methyl-6- (pentylamino) pyrimidin- 5 -yl) methyl) phenyl)acetate

Publications (3)

Publication Number Publication Date
JP2012527442A JP2012527442A (ja) 2012-11-08
JP2012527442A5 true JP2012527442A5 (https=) 2013-07-04
JP5717727B2 JP5717727B2 (ja) 2015-05-13

Family

ID=40862774

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012511355A Expired - Fee Related JP5717727B2 (ja) 2009-05-21 2010-05-20 ２−（４−（（２−アミノ−４−メチル−６−（ペンチルアミノ）ピリミジン−５−イル）メチル）フェニル）酢酸４−（ジメチルアミノ）ブチルの二サッカリン塩、二フマル酸塩、二ｌ−ヒドロキシ−２−ナフトエ酸塩および一安息香酸塩

Country Status (30)

Country Link
US (1) US8476288B2 (https=)
EP (1) EP2435412B1 (https=)
JP (1) JP5717727B2 (https=)
KR (1) KR101709363B1 (https=)
CN (1) CN102596917B (https=)
AR (1) AR076597A1 (https=)
AU (1) AU2010250920B2 (https=)
BR (1) BRPI1012198A8 (https=)
CA (1) CA2760765A1 (https=)
CL (1) CL2011002941A1 (https=)
CO (1) CO6440532A2 (https=)
CR (1) CR20110611A (https=)
CU (1) CU24053B1 (https=)
DO (1) DOP2011000360A (https=)
EA (1) EA021854B1 (https=)
EC (1) ECSP11011469A (https=)
ES (1) ES2566912T3 (https=)
GB (1) GB0908772D0 (https=)
HN (1) HN2011003072A (https=)
IL (1) IL216280A0 (https=)
MX (1) MX2011012344A (https=)
NI (1) NI201100205A (https=)
NZ (1) NZ596118A (https=)
PE (1) PE20120989A1 (https=)
SA (1) SA110310402B1 (https=)
SG (1) SG175322A1 (https=)
TW (1) TW201100389A (https=)
UY (1) UY32649A (https=)
WO (1) WO2010133882A1 (https=)
ZA (1) ZA201109383B (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8012964B2 (en) 2004-03-26 2011-09-06 Dainippon Sumitomo Pharma Co., Ltd. 9-substituted 8-oxoadenine compound
US8138172B2 (en) * 2006-07-05 2012-03-20 Astrazeneca Ab 8-oxoadenine derivatives acting as modulators of TLR7
TW200831105A (en) 2006-12-14 2008-08-01 Astrazeneca Ab Novel compounds
ES2373616T3 (es) * 2007-03-19 2012-02-07 Astrazeneca Ab Compuestos de 8-oxo-adenina 9 sustituidos como moduladores del receptor de tipo toll (tlr7).
ES2457316T3 (es) * 2007-03-19 2014-04-25 Astrazeneca Ab Compuestos 8-oxo-adenina 9 sustituidos como moduladores del receptor similares a toll (TLR7)
AR065784A1 (es) * 2007-03-20 2009-07-01 Dainippon Sumitomo Pharma Co Derivados de 8-oxo adenina,medicamentos que los contienen y usos como agentes terapeuticos para enfermedades alergicas, antivirales o antibacterianas.
JPWO2008114819A1 (ja) * 2007-03-20 2010-07-08 大日本住友製薬株式会社 新規アデニン化合物
HRP20120895T1 (hr) * 2007-05-08 2012-11-30 Astrazeneca Ab Imidazokinolini sa imuno-modulacijskim svojstvima
CA2691444C (en) 2007-06-29 2016-06-14 Gilead Sciences, Inc. Purine derivatives and their use as modulators of toll-like receptor 7
PE20091236A1 (es) * 2007-11-22 2009-09-16 Astrazeneca Ab Derivados de pirimidina como immunomoduladores de tlr7
PE20091156A1 (es) 2007-12-17 2009-09-03 Astrazeneca Ab Sales de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8-dihidro-9h-purin-9-il)propil](3-morfolin-4-ilpropil)amino]metil}fenil)acetato de metilo
RS53347B (sr) 2008-12-09 2014-10-31 Gilead Sciences, Inc. Modulatori toll-sličnih receptora
JP5694345B2 (ja) 2009-10-22 2015-04-01 ギリアード サイエンシーズ， インコーポレイテッド Ｔｏｌｌ様受容体の調節因子
JP2013512859A (ja) * 2009-12-03 2013-04-18 大日本住友製薬株式会社 トール様受容体（ｔｌｒ）を介して作用するイミダゾキノリン
US20110150836A1 (en) * 2009-12-22 2011-06-23 Gilead Sciences, Inc. Methods of treating hbv and hcv infection
CN103370317B (zh) 2010-12-16 2015-10-07 阿斯利康(瑞典)有限公司 可用于治疗的咪唑并[4,5-c]喹啉-1-基衍生物
ES2627433T3 (es) 2010-12-17 2017-07-28 Sumitomo Dainippon Pharma Co., Ltd. Derivados de purina
JP6184423B2 (ja) 2012-05-18 2017-08-23 大日本住友製薬株式会社 カルボン酸化合物
JP6522732B2 (ja) 2014-07-11 2019-05-29 ギリアード サイエンシーズ， インコーポレイテッド Ｈｉｖを治療するためのトール様受容体の調節因子
SG11201701520TA (en) 2014-09-16 2017-04-27 Gilead Sciences Inc Solid forms of a toll-like receptor modulator
WO2018095426A1 (zh) 2016-11-28 2018-05-31 江苏恒瑞医药股份有限公司 吡唑并杂芳基类衍生物、其制备方法及其在医药上的应用
JP2020520379A (ja) 2017-05-18 2020-07-09 江▲蘇▼恒瑞医▲薬▼股▲フン▼有限公司Ｊｉａｎｇｓｕ Ｈｅｎｇｒｕｉ Ｍｅｄｉｃｉｎｅ Ｃｏ．， Ｌｔｄ． ヘテロアリール−ピラゾール誘導体ならびにその調製方法および医学的適用
MX2020012651A (es) 2018-05-25 2021-02-02 Jiangsu Hengrui Medicine Co Forma de cristal de clorhidrato de derivado de pirazoloheteroarilo, y metodo de preparacion.
TWI810456B (zh) 2019-05-22 2023-08-01 美商基利科學股份有限公司 Tlr7調節化合物及hiv疫苗之組合

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1375162A (https=) 1970-10-22 1974-11-27
GB1546937A (en) * 1976-07-29 1979-05-31 Beecham Group Ltd 2,4-diaminopyrimidine derivatives
ZA848968B (en) * 1983-11-18 1986-06-25 Riker Laboratories Inc 1h-imidazo(4,5-c)quinolines and 1h-imidazo(4,5-c)quinolin-4-amines
IL73534A (en) * 1983-11-18 1990-12-23 Riker Laboratories Inc 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
IL78643A0 (en) * 1985-05-02 1986-08-31 Wellcome Found Purine derivatives,their preparation and pharmaceutical compositions containing them
DE3603577A1 (de) * 1986-02-06 1987-08-13 Joachim K Prof Dr Seydel Neue substituierte 2,4-diamino-5-benzylpyrimidine, deren herstellung und deren verwendung als arzneimittel mit antibakterieller wirksamkeit
JPH08165292A (ja) 1993-10-07 1996-06-25 Techno Res Kk アデニン誘導体、その製造法及び用途
US5994361A (en) * 1994-06-22 1999-11-30 Biochem Pharma Substituted purinyl derivatives with immunomodulating activity
FI971413L (fi) * 1994-10-05 1997-04-04 Chiroscience Ltd Puriini- ja guaniiniyhdisteet PNP:n estäjinä
ES2232871T3 (es) * 1996-07-03 2005-06-01 Sumitomo Pharmaceuticals Company, Limited Nuevos derivados de purina.
DE69817393T2 (de) * 1997-11-28 2004-06-17 Sumitomo Pharmaceuticals Co., Ltd. Neue heterozyklische verbindungen
TW572758B (en) 1997-12-22 2004-01-21 Sumitomo Pharma Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives
JP4189048B2 (ja) 1997-12-26 2008-12-03 大日本住友製薬株式会社 複素環化合物
JP2003504301A (ja) 1998-04-01 2003-02-04 ブリストル−マイヤーズ スクイブ ファーマ カンパニー インテグリンアンタゴニスト
ES2221414T3 (es) * 1998-08-27 2004-12-16 Sumitomo Pharmaceuticals Company, Limited Derivados de pirimidina.
CZ27399A3 (cs) * 1999-01-26 2000-08-16 Ústav Experimentální Botaniky Av Čr Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
WO2001007027A2 (en) 1999-07-22 2001-02-01 Vertex Pharmaceuticals Incorporated Pyrimidine derivatives for the treatment of viral diseases
WO2002004449A2 (en) 2000-07-07 2002-01-17 Neotherapeutics, Inc. Methods for treatment of conditions affected by activity of multidrug transporters
US7157465B2 (en) * 2001-04-17 2007-01-02 Dainippon Simitomo Pharma Co., Ltd. Adenine derivatives
AU2003246102A1 (en) * 2002-06-27 2004-01-19 Genox Research, Inc. Method of examining allergic disease and drug for treating the same
MXPA05003193A (es) 2002-09-27 2005-06-08 Sumitomo Pharma Compuesto de adenina novedoso y uso del mismo.
MXPA05013922A (es) * 2003-06-20 2006-02-24 Coley Pharm Group Inc Antagonistas de receptor tipo toll de molecula pequena.
US7442698B2 (en) 2003-07-24 2008-10-28 Amgen Inc. Substituted heterocyclic compounds and methods of use
JP2007504232A (ja) * 2003-09-05 2007-03-01 アナディス ファーマシューティカルズ インク Ｃ型肝炎ウイルス感染治療用のｔｌｒ７リガンド及びそのプロドラッグの投与
WO2005092892A1 (ja) 2004-03-26 2005-10-06 Dainippon Sumitomo Pharma Co., Ltd. ８−オキソアデニン化合物
US8012964B2 (en) 2004-03-26 2011-09-06 Dainippon Sumitomo Pharma Co., Ltd. 9-substituted 8-oxoadenine compound
KR100700676B1 (ko) 2005-06-24 2007-03-28 (주) 비엔씨바이오팜 6―（4―치환된―아닐리노）피리미딘 유도체, 그 제조방법및 이를 포함하는 항바이러스용 약학적 조성물
US7759350B2 (en) 2005-09-15 2010-07-20 Orchid Research Laboratories Ltd. Pyrimidine carboxamides
GB0518819D0 (en) * 2005-09-15 2005-10-26 Astrazeneca Ab Therapeutic agents
TW200801003A (en) 2005-09-16 2008-01-01 Astrazeneca Ab Novel compounds
EP1939200A4 (en) 2005-09-22 2010-06-16 Dainippon Sumitomo Pharma Co NEW ADENINE CONNECTION
US20090105212A1 (en) * 2005-09-22 2009-04-23 Dainippon Sumitomo Pharma Co., Ltd. a corporation of Japan Novel adenine compound
JPWO2007034817A1 (ja) 2005-09-22 2009-03-26 大日本住友製薬株式会社 新規アデニン化合物
JPWO2007034881A1 (ja) * 2005-09-22 2009-03-26 大日本住友製薬株式会社 新規アデニン化合物
JPWO2007034882A1 (ja) 2005-09-22 2009-03-26 大日本住友製薬株式会社 新規アデニン化合物
TW200745114A (en) * 2005-09-22 2007-12-16 Astrazeneca Ab Novel compounds
UY29827A1 (es) * 2005-10-03 2007-05-31 Astrazeneca Ab 2-amina-pirimidina-4-(2-metil-1-(tetrahidro-2h-piran-4-il)-1-imidazol-5-y1) sustituidas y sus derivados, composiciones farmacéuticas que las contienen, procesos para su preparación y aplicaciones
AR057987A1 (es) * 2005-11-24 2008-01-09 Astrazeneca Ab Compuestos agonistas de cb1 (receptor cannabinoide)
TW200817391A (en) 2006-06-30 2008-04-16 Astrazeneca Ab Novel compounds
US8138172B2 (en) * 2006-07-05 2012-03-20 Astrazeneca Ab 8-oxoadenine derivatives acting as modulators of TLR7
CL2007002231A1 (es) * 2006-08-02 2008-04-11 Basf Ag Uso de compuestos derivados de 5-(het) arilpirimidina para combatir hongos daninos; compuestos derivados de 5-(het) arilpirimidina; agente fungicida; y agente farmaceutico.
TW200831105A (en) * 2006-12-14 2008-08-01 Astrazeneca Ab Novel compounds
WO2008083465A1 (en) 2007-01-08 2008-07-17 University Health Network Pyrimidine derivatives as anticancer agents
ES2457316T3 (es) * 2007-03-19 2014-04-25 Astrazeneca Ab Compuestos 8-oxo-adenina 9 sustituidos como moduladores del receptor similares a toll (TLR7)
ES2373616T3 (es) * 2007-03-19 2012-02-07 Astrazeneca Ab Compuestos de 8-oxo-adenina 9 sustituidos como moduladores del receptor de tipo toll (tlr7).
JPWO2008114819A1 (ja) 2007-03-20 2010-07-08 大日本住友製薬株式会社 新規アデニン化合物
AR065784A1 (es) 2007-03-20 2009-07-01 Dainippon Sumitomo Pharma Co Derivados de 8-oxo adenina,medicamentos que los contienen y usos como agentes terapeuticos para enfermedades alergicas, antivirales o antibacterianas.
HRP20120895T1 (hr) 2007-05-08 2012-11-30 Astrazeneca Ab Imidazokinolini sa imuno-modulacijskim svojstvima
BRPI0816278A2 (pt) * 2007-09-05 2015-09-22 Pfizer Ltd forma sal
PE20091236A1 (es) * 2007-11-22 2009-09-16 Astrazeneca Ab Derivados de pirimidina como immunomoduladores de tlr7
PE20091156A1 (es) 2007-12-17 2009-09-03 Astrazeneca Ab Sales de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8-dihidro-9h-purin-9-il)propil](3-morfolin-4-ilpropil)amino]metil}fenil)acetato de metilo
WO2009091032A1 (ja) 2008-01-17 2009-07-23 Dainippon Sumitomo Pharma Co., Ltd. アデニン化合物の製造方法
JPWO2009091031A1 (ja) 2008-01-17 2011-05-26 大日本住友製薬株式会社 アデニン化合物の製造方法
WO2010033074A1 (en) 2008-09-18 2010-03-25 Astrazeneca Ab Use of a tlr7 agonist for the treatment of cancer
JP2013512859A (ja) * 2009-12-03 2013-04-18 大日本住友製薬株式会社 トール様受容体（ｔｌｒ）を介して作用するイミダゾキノリン

Similar Documents

Publication Publication Date Title
JP2012527442A5 (https=)
CN102596917B (zh) 2-(4-((2-氨基-4-甲基-6-(戊基氨基)嘧啶-5-基)甲基)苯基)乙酸4-(二甲基氨基)丁酯的二糖精盐、二富马酸盐、二-(1-羟基-萘-2-甲酸)盐和单苯甲酸盐
JP2019530677A (ja) Ｅｇｆｒ阻害剤の薬学的な塩及びその結晶形、製造方法並びに使用
JP2020518662A (ja) 化合物の結晶多形、その製造方法及び用途
KR20260041111A (ko) 아다그라시브 염의 결정질 형태
JP2018520205A (ja) レンバチニブメシル酸塩の新規結晶形及びその製造方法
JP6830888B2 (ja) Ｊａｋ阻害剤の硫酸水素塩の結晶形およびその製造方法
TW200526644A (en) Process for preparing amino crotonyl compounds
JP5822831B2 (ja) チオトロピウム臭化物の無水物
CN107915725A (zh) Azd9291的药用盐及其制备方法
JP2013538849A5 (https=)
JPWO2016181990A1 (ja) アザ二環式化合物の結晶
ES2533681T3 (es) Formas cristalinas de sales de Prasugrel
JP2024500101A (ja) 化合物の固体形態
CN109456279B (zh) 噻唑氨基苯甲酰胺乙酸酯衍生物及其用途
JP6872179B2 (ja) テノホビルプロドラッグの新規な多結晶形並びにその製造方法及び用途
CN104918937A (zh) 曲美替尼及其溶剂化物的晶型、其制备方法、含有它们的药物组合物及其用途
CN105408329A (zh) 呈晶体形式的达沙替尼的盐
JP2012512145A (ja) フリバンセリンの結晶性の塩形態
JP2016512518A (ja) ベムラフェニブ塩酸塩の固体形態
CN102875634A (zh) 2-氰基-3,12-二氧代齐墩果-1,9(11)-二烯-28-酸甲酯的几种晶型
CN104628677A (zh) 一种沃替西汀有机酸盐晶型及其制备方法
TW201829420A (zh) [(1S)-1-[(2S,4R,5R)-5-(5-胺基-2-酮基-噻唑并[4,5-d]嘧啶-3-基)-4-羥基-四氫呋喃-2-基]丙基]乙酸酯之新穎固態形式
US12384784B2 (en) Polymorphs of Acalabrutinib, a Bruton's tyrosine kinase inhibitor
CN101353325B (zh) 稳定型盐酸伊伐布雷定结晶及其制备方法